UnknownPhase 2

Effect of Platelet-rich Factor on Implant Stability and Bone Resorption in the Lower Posterior Mandible

Iran30 participantsStarted 2014-09

Plain-language summary

The main objective of this clinical trial study is to consider the effect of Platelet-Rich-Factor (PRF) on implant stability and marginal bone resorption around dental implants.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who have 1 or 2 missing teeth in both side of posterior mandible * adequate bone quantity and quality at the implant site * the implant sites with at least 3 months of healing after extraction, * patients well motivated for implant therapy and maintaining good oral hygiene * the implant sites with width and length to installation of an implant of 4.5 mm x 11.5 mm. * Patients who gave written informed consent Exclusion Criteria: * • medically compromised or patients taking any immunosuppressive drugs which may complicate the treatment outcome * infection around the implant site * history of bruxism/parafunctional habits * patients with history of any bleeding disorder or on anti-coagulant therapy. * pregnant patients

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

implant loss

Timeframe: 6 months

Trial details

NCT IDNCT02349620

SponsorReza Tabrizi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-09

Contact for this trial

Reza Tabrizi, DMD

09125850829 Tabmed@gmail.com

View on ClinicalTrials.gov More Osseointegrated Dental Implantation trials

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.